These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17005675)
1. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. Fernandez-Borges N; Brun A; Whitton JL; Parra B; Diaz-San Segundo F; Salguero FJ; Torres JM; Rodriguez F J Virol; 2006 Oct; 80(20):9970-6. PubMed ID: 17005675 [TBL] [Abstract][Full Text] [Related]
2. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie. Nitschke C; Flechsig E; van den Brandt J; Lindner N; Lührs T; Dittmer U; Klein MA Vet Microbiol; 2007 Aug; 123(4):367-76. PubMed ID: 17499458 [TBL] [Abstract][Full Text] [Related]
3. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405 [TBL] [Abstract][Full Text] [Related]
4. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells. Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482 [TBL] [Abstract][Full Text] [Related]
5. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses. Hedlin PD; Cashman NR; Li L; Gupta J; Babiuk LA; Potter AA; Griebel P; Napper S Vaccine; 2010 Jan; 28(4):981-8. PubMed ID: 19925901 [TBL] [Abstract][Full Text] [Related]
6. Immune responses in wild-type mice against prion proteins induced using a DNA prime-protein boost strategy. Han Y; Li Y; Song J; Wang Y; Shi Q; Chen C; Zhang B; Guo Y; Li C; Han J; Dong X Biomed Environ Sci; 2011 Oct; 24(5):523-9. PubMed ID: 22108419 [TBL] [Abstract][Full Text] [Related]
7. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC. Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583 [TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Polymenidou M; Heppner FL; Pellicioli EC; Urich E; Miele G; Braun N; Wopfner F; Schätzl HM; Becher B; Aguzzi A Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14670-6. PubMed ID: 15292505 [TBL] [Abstract][Full Text] [Related]
10. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575 [TBL] [Abstract][Full Text] [Related]
11. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice. Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S Prion; 2013; 7(5):434-9. PubMed ID: 24105298 [TBL] [Abstract][Full Text] [Related]
13. Cell mediated immune responses against human prion protein. Bainbridge J; Walker B Clin Exp Immunol; 2003 Sep; 133(3):310-7. PubMed ID: 12930355 [TBL] [Abstract][Full Text] [Related]
14. Anti-PrP antibodies detected at terminal stage of prion-affected mouse. Sassa Y; Kataoka N; Inoshima Y; Ishiguro N Cell Immunol; 2010; 263(2):212-8. PubMed ID: 20417929 [TBL] [Abstract][Full Text] [Related]
15. Vaccine approaches to prevent and treat prion infection : progress and challenges. Müller-Schiffmann A; Korth C BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090 [TBL] [Abstract][Full Text] [Related]
16. Mucosal vaccination delays or prevents prion infection via an oral route. Goñi F; Knudsen E; Schreiber F; Scholtzova H; Pankiewicz J; Carp R; Meeker HC; Rubenstein R; Brown DR; Sy MS; Chabalgoity JA; Sigurdsson EM; Wisniewski T Neuroscience; 2005; 133(2):413-21. PubMed ID: 15878645 [TBL] [Abstract][Full Text] [Related]
17. Anti-prion antibodies for prophylaxis following prion exposure in mice. Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623 [TBL] [Abstract][Full Text] [Related]
18. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP. Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315 [TBL] [Abstract][Full Text] [Related]
19. Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice. Sacquin A; Chaigneau T; Defaweux V; Adam M; Schneider B; Bruley Rosset M; Eloit M Brain Behav Immun; 2012 Aug; 26(6):919-30. PubMed ID: 22522067 [TBL] [Abstract][Full Text] [Related]
20. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein. Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]